| 1 |
Daniel Davenport |
Globus Medical |
9 |
| 1 |
Raymond L. Sharrah |
Streamlight |
9 |
| 3 |
Freddie L. Singleton |
Dow Global Technologies |
7 |
| #4 |
Milan George |
Globus Medical |
5 |
| #4 |
Debashish Purkayastha |
Interdigital Patent Holdings |
5 |
| #6 |
William E. Duffield |
Globus Medical |
4 |
| #6 |
William P. McDonough |
Depuy Synthes Products |
4 |
| #6 |
William Henry Miller |
Smithkline Beecham Limited |
4 |
| #6 |
Mark D. Westmeyer |
Rohm And Haas |
4 |
| #6 |
Neil W. Johnson |
Glaxosmithkline |
4 |
| #6 |
Robert E. Lee TROUT |
Venatorx Pharmaceuticals |
4 |
| #12 |
Steven David Knight |
Cytokinetics |
3 |
| #12 |
Edward J. McShane, III |
Institute For Musculoskeletal Science And Education |
3 |
| #12 |
Xinrong Tian |
Glaxosmithkline |
3 |
| #12 |
Joseph Manna |
Rohm And Haas |
3 |
| #12 |
Joseph E. Pero |
Glaxosmithkline Intellectual Property Development Limited |
3 |
| #12 |
Robert A. Johnson |
Unisys |
3 |
| #12 |
Kenneth A. Newlander |
Smithkline Beecham Limited |
3 |
| #19 |
Jiri Kasparec |
Glaxosmithkline Intellectual Property (No. 4) Limited |
2 |
| #19 |
James Raymond Brown |
Smithkline Beecham Limited |
2 |
| #19 |
Francisco Henriquez |
Novartis Ag |
2 |
| #19 |
Scott C. Hergenhan |
Interdigital Patent Holdings |
2 |
| #19 |
Ngocdiep T. Le |
Novartis Ag |
2 |
| #19 |
Douglas J. DeMarini |
Novartis Ag |
2 |
| #19 |
Joelle Lorraine Burgess |
Glaxosmithkline |
2 |
| #19 |
John James Dougherty |
GE |
2 |
| #19 |
Louis Lafrance |
Glaxosmithkline |
2 |
| #19 |
Alexander Joseph Reif |
Merck |
2 |
| #19 |
Paul A. Benensky |
Certainteed |
2 |
| #19 |
Manish Mundra |
Dow Global Technologies |
2 |
| #19 |
Gregg A. Charlton |
Interdigital Patent Holdings |
2 |
| #19 |
Dennis Murphy |
Glaxosmithkline Biologicals Sa |
2 |
| #19 |
Stuart Paul Romeril |
Glaxosmithkline |
2 |
| #19 |
Stephen A. Koch |
Certainteed |
2 |
| #19 |
Meagan B. Rouse |
Glaxosmithkline |
2 |
| #19 |
Charlotte M. Ciccone |
Kimberly-Clark Worldwide |
2 |
| #19 |
Rick R. Lesniewski |
Abb Vie |
2 |
| #19 |
Mark A. Destefano |
Amgen |
2 |
| #19 |
Bruce E. Tomczuk |
3-Dimensional Pharmaceuticals |
2 |
| #19 |
Michael T. Rudd |
Merck |
2 |
| #19 |
Mahase Nardeo |
Medical Components |
2 |
| #42 |
Colby Barth |
Juniper Networks |
1 |
| #42 |
Seth Grant |
Glaxosmithkline |
1 |
| #42 |
Thomas H. Faitg |
Glaxosmithkline |
1 |
| #42 |
Ericka Lynn Killian |
Rohm And Haas |
1 |
| #42 |
Nicholas D. Adams |
Cytokinetics |
1 |
| #42 |
Neil David Pearson |
Glaxo Group Limited |
1 |
| #42 |
Peter F. Lebowitz |
Glaxosmithkline |
1 |
| #42 |
William C. Miles |
Angus Chemical |
1 |
| #42 |
Joshi M. Ramanjulu |
Glaxosmithkline Intellectual Property Development Limited |
1 |